Kevin Mayo
Corporate Officer/Principal at University of the Sciences in Philadelphia
Profile
Kevin Mayo is Vice President of Bridgehead International Ltd.
He is an Adjunct Professor of the University of the Sciences in Philadelphia.
He is a Co-Chairman of the International Society for Pharmacoecomics & Outcomes Research.
Previously, he worked at Daiichi Sankyo Inc., Novartis Pharma AG, Pharmacia Corp., and Hoffmann La Roche.
He has experience in pharmaceutical companies and payer organisations.
Dr. Mayo received a PhD in Pharmaceutical Administration from the University of Louisiana.
Kevin Mayo active positions
Companies | Position | Start |
---|---|---|
University of the Sciences in Philadelphia | Corporate Officer/Principal | - |
Former positions of Kevin Mayo
Companies | Position | End |
---|---|---|
Bridgehead International Ltd.
Bridgehead International Ltd. Miscellaneous Commercial ServicesCommercial Services Bridgehead International Ltd. provides biopharmaceutical consulting services. It provides services to companies in the biotechnology, pharmaceutical, and health care fields. It offers scientific, medical, economic, technical and commercial advices & intellectual property skills to firms developing new health care products .The company was founded in 1995 and is headquartered in Melton Mowbray, UK. | Corporate Officer/Principal | 2012-03-01 |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Corporate Officer/Principal | - |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Training of Kevin Mayo
University of Louisiana at Monroe | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Bridgehead International Ltd.
Bridgehead International Ltd. Miscellaneous Commercial ServicesCommercial Services Bridgehead International Ltd. provides biopharmaceutical consulting services. It provides services to companies in the biotechnology, pharmaceutical, and health care fields. It offers scientific, medical, economic, technical and commercial advices & intellectual property skills to firms developing new health care products .The company was founded in 1995 and is headquartered in Melton Mowbray, UK. | Commercial Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
- Stock Market
- Insiders
- Kevin Mayo